| 000 | 01367 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250511210811.0 | ||
| 264 | 0 | _c19910905 | |
| 008 | 199109s 0 0 eng d | ||
| 022 | _a0031-4005 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBlanche, S | |
| 245 | 0 | 0 |
_aLow-dose zidovudine in children with an human immunodeficiency virus type 1 infection acquired in the perinatal period. _h[electronic resource] |
| 260 |
_bPediatrics _cAug 1991 |
||
| 300 |
_a364-70 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xdrug therapy |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Tolerance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization, Passive |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 |
_aKetoconazole _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOpportunistic Infections _xprevention & control |
| 650 | 0 | 4 |
_aTrimethoprim, Sulfamethoxazole Drug Combination _xtherapeutic use |
| 650 | 0 | 4 |
_aZidovudine _xadministration & dosage |
| 700 | 1 | _aDuliege, A M | |
| 700 | 1 | _aNavarette, M S | |
| 700 | 1 | _aTardieu, M | |
| 700 | 1 | _aDebré, M | |
| 700 | 1 | _aRouzioux, C | |
| 700 | 1 | _aSeldrup, J | |
| 700 | 1 | _aKouzan, S | |
| 700 | 1 | _aGriscelli, C | |
| 773 | 0 |
_tPediatrics _gvol. 88 _gno. 2 _gp. 364-70 |
|
| 999 |
_c1868144 _d1868144 |
||